These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3783412

  • 1. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
    Tezuka M, Chiba Y, Okada S, Tamemasa O.
    J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of potentiation of antitumor activity of 5-fluorouracil by ribothymidine in a mouse tumor system.
    Tezuka M, Chiba Y, Tamemasa O, Okada S.
    J Pharmacobiodyn; 1986 Dec; 9(12):962-9. PubMed ID: 3572717
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M, Nakajima Y, Kuretani K, Hoshi A.
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [Abstract] [Full Text] [Related]

  • 4. Intraperitoneal injection of dipyridamole increases the life span of tumor bearing mice treated with fluorouracil.
    Barberl-Heyob M, Merlin JL, Weber B.
    In Vivo; 1992 Apr; 6(5):535-40. PubMed ID: 1457748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M, Yamaguchi T, Ueda H, Shiraishi N, Komiyama S, Akiyama S, Ogata J, Kuwano M.
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
    Keizer HJ, Pauwels R, Landuyt W, Balzarini J, van der Schueren E, De Clercq E.
    Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides.
    Tamemasa O, Tezuka M.
    Gan; 1983 Apr; 74(2):285-90. PubMed ID: 6407888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Luteolin and 5-flurouracil act synergistically to induce cellular weapons in experimentally induced Solid Ehrlich Carcinoma: Realistic role of P53; a guardian fights in a cellular battle.
    Soliman NA, Abd-Ellatif RN, ELSaadany AA, Shalaby SM, Bedeer AE.
    Chem Biol Interact; 2019 Sep 01; 310():108740. PubMed ID: 31288002
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M.
    Anticancer Res; 1993 Sep 01; 13(2):369-73. PubMed ID: 8517649
    [Abstract] [Full Text] [Related]

  • 17. Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.
    Tezuka M, Sugiyama H, Tamemasa O, Inaba M.
    Gan; 1982 Feb 01; 73(1):70-6. PubMed ID: 7117749
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of 5-fluorouracil in combination with methoxyphenyl maleamic acid in murine tumors.
    Indap MA, Ambaye RY.
    J Postgrad Med; 1991 Oct 01; 37(4):211-5. PubMed ID: 1841970
    [Abstract] [Full Text] [Related]

  • 19. [Antitumor effects of different combinations of oridonin, bleomycin A5 and nitrocaphane].
    Zhang TM, Shou MG, Wang MY.
    Zhongguo Yao Li Xue Bao; 1986 Sep 01; 7(5):457-60. PubMed ID: 2438898
    [No Abstract] [Full Text] [Related]

  • 20. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O, Mori H, Kitaichi K, Koda A, Kato T.
    Jpn J Pharmacol; 1992 Aug 01; 59(4):469-76. PubMed ID: 1434142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.